Seize the opportunity

Underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions


  • Douglas P. Clark MD

    Corresponding author
    1. Departments of Oncology and Pathology, The Johns Hopkins School of Medicine, Baltimore, Maryland
    • The Johns Hopkins Hospital, Rm. 406 Pathology Bldg., 600 N. Wolfe Street, Baltimore, MD 21287
    Search for more papers by this author
    • Fax: (410) 614-9556


Molecularly targeted agents are increasingly utilized to treat cancer. Unfortunately, biomarkers to guide this therapy are infrequently applied to FNA samples.